China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	21.65B
Revenue (ttm)	51.47B
Net Income (ttm)	1.95B
Shares Out	754.50M
EPS (ttm)	2.58
PE Ratio	11.11
Forward PE	10.37
Dividend	0.80 (2.79%)
Ex-Dividend Date	Jun 18, 2025

Volume	4,766,023
Average Volume	4,214,062
Open	28.70
Previous Close	28.69
Day's Range	28.62 - 29.05
52-Week Range	27.57 - 36.72
Beta	0.34
RSI	45.27
Earnings Date	Oct 23, 2025

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. operates as subsidiary Sinopharm Group Co. Ltd.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,104
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2024, SHA:600511's revenue was 50.60 billion, an increase of 1.81% compared to the previous year's 49.70 billion. Earnings were 2.00 billion, a decrease of -6.80%.